4.6 Review

Integration of artificial intelligence in lung cancer: Rise of the machine

Related references

Note: Only part of the references are listed.
Article Oncology

Cancer statistics, 2022

Rebecca L. Siegel et al.

Summary: Each year, the American Cancer Society compiles data on cancer occurrence and outcomes in the United States. The latest data shows that breast and prostate cancer progress has stagnated, while lung cancer has shown improvements in survival rates. Lung cancer incidence for advanced disease has declined while localized-stage rates have increased, resulting in higher survival rates. Mortality patterns align with incidence trends, with lung cancer deaths declining rapidly, breast cancer deaths slowing, and prostate cancer deaths stabilizing.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

Article Oncology

Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer

David R. Spigel et al.

Summary: The study examined the efficacy of consolidation durvalumab in patients with non-small-cell lung cancer, showing significant improvements in overall survival and progression-free survival, with manageable safety. The 5-year follow-up data continued to demonstrate the positive effects of durvalumab on survival and disease progression.

JOURNAL OF CLINICAL ONCOLOGY (2022)

Article Oncology

Postoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 involvement (Lung ART): an open-label, randomised, phase 3 trial

Cecile Le Pechoux et al.

Summary: This study aimed to investigate whether three-dimensional conformal radiotherapy (3D PORT) should be part of the standard treatment for patients with non-small-cell lung cancer (NSCLC) with N2 involvement. The results showed that 3-year disease-free survival was slightly higher in patients with PORT compared to those without, but the difference was not significant.

LANCET ONCOLOGY (2022)

Article Oncology

Non-Small Cell Lung Cancer, Version 3.2022

David S. Ettinger et al.

Summary: This passage introduces the recommended management for non-small cell lung cancer (NSCLC) in the NCCN Clinical Practice Guidelines, with a focus on targeted therapies for patients with metastatic NSCLC and actionable mutations.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2022)

Article Oncology

First-line PD-1/PD-L1 inhibitors plus chemotherapy versus bevacizumab plus chemotherapy for advanced non-squamous non-small cell lung cancer: A Bayesian network meta-analysis of randomized controlled trials

Jinzhao Zhai et al.

Summary: This study compared the efficacy of immune checkpoint inhibitor (ICI) plus chemotherapy and bevacizumab plus chemotherapy in the first-line treatment of non-squamous non-small cell lung cancer. The results showed that ICI-chemotherapy was associated with better overall survival compared to Bev-chemotherapy, while there were no differences in progression-free survival, overall response rate, and grade >= 3 treatment-related adverse events between the two treatments.

CANCER MEDICINE (2022)

Review Pharmacology & Pharmacy

Impact of Smoking on Response to the First-Line Treatment of Advanced ALK-Positive Non-Small Cell Lung Cancer: A Bayesian Network Meta-Analysis

Kehai Lin et al.

Summary: The impact of smoking on the efficacy of first-line treatment for ALK-positive NSCLC is controversial. This systematic review and meta-analysis found that smoking may not affect the treatment efficacy in the overall population, but alectinib may perform better in the smoking Asian population. Furthermore, lorlatinib in never-smokers and low-dose alectinib in smokers could be considered optimal first-line therapy for advanced ALK-positive NSCLC.

FRONTIERS IN PHARMACOLOGY (2022)

Article Medicine, General & Internal

A Bayesian Network Meta-Analysis of First-Line Treatments for Non-Small Cell Lung Cancer with High Programmed Death Ligand-1 Expression

Jung Han Kim et al.

Summary: The study conducted a Bayesian network meta-analysis to suggest frontline treatments for advanced NSCLC with high PD-L1 expression, and found that ICI plus chemotherapy with/without bevacizumab might be the best options in terms of overall survival.

JOURNAL OF CLINICAL MEDICINE (2022)

Article Oncology

Machine learning to refine prognostic and predictive nodal burden thresholds for post-operative radiotherapy in completely resected stage III-N2 non-small cell lung cancer

Reza Zarinshenas et al.

Summary: This study used machine learning algorithms to analyze the feasibility of post-operative radiotherapy in patients with completely resected N2 non-small-cell lung cancer. The results showed that post-operative radiotherapy significantly improved overall survival in patients with a lymph node burden of 3+ positive lymph nodes or a lymph node ratio of 0.34+.

RADIOTHERAPY AND ONCOLOGY (2022)

Article Oncology

Improved prediction of radiation pneumonitis by combining biological and radiobiological parameters using a data-driven Bayesian network analysis

Tonaye Hinton et al.

Summary: This study identified a combined biomarker signature of circulating miRNAs and cytokines that can better predict a targetable RP2 pathway. The results suggest that the activation of the TNF alpha-NF kappa B inflammatory pathway plays a key role in RP and could be specifically ameliorated by etanercept.

TRANSLATIONAL ONCOLOGY (2022)

Article Medicine, General & Internal

Investigation of the optimal platinum-based regimen in the postoperative adjuvant chemotherapy setting for early-stage resected non-small lung cancer: a Bayesian network meta-analysis

Lan-Lan Pang et al.

Summary: This study compared the efficacy and safety of different platinum adjuvant chemotherapy regimens for early-stage resected non-small-cell lung cancer (NSCLC). The results showed that the chemotherapy group had a significant advantage in terms of relapse-free survival (RFS) and overall survival (OS) compared to the observation group. Only the 'cisplatin_vinorelbine' regimen had a significant advantage in terms of RFS and OS. The study also found that the incidence of hematological toxicities and nausea/vomiting was not significantly higher in the 'cisplatin_vinorelbine' arm compared to other chemotherapy regimens.

BMJ OPEN (2022)

Article Pharmacology & Pharmacy

Efficacy and Safety of Bevacizumab Biosimilars Compared With Reference Biologics in Advanced Non-small Cell Lung Cancer or Metastatic Colorectal Cancer Patients: A Network Meta-Analysis

Xinyi Xu et al.

Summary: This study systematically summarized the efficacy and safety of bevacizumab biosimilars in patients with advanced non-small cell lung cancer and metastatic colorectal cancer. Pairwise meta-analysis and Bayesian network meta-analysis showed no significant difference in efficacy and safety between bevacizumab biosimilars and reference biologics, as well as among different treatment regimens. However, the certainty of the evidence was assessed as low.

FRONTIERS IN PHARMACOLOGY (2022)

Article Computer Science, Information Systems

Integrative Network Modeling Highlights the Crucial Roles of Rho-GDI Signaling Pathway in the Progression of non-Small Cell Lung Cancer

Saransh Gupta et al.

Summary: Using machine learning and protein-protein interaction networks, we identified key genes and pathways involved in the onset and progression of NSCLC, particularly those related to Rho GTPase signaling. Our study offers promising avenues for early prediction, targeted therapy, and improved clinical outcomes in NSCLC.

IEEE JOURNAL OF BIOMEDICAL AND HEALTH INFORMATICS (2022)

Review Oncology

Utilization of model-agnostic explainable artificial intelligence frameworks in oncology: a narrative review

Colton Ladbury et al.

Summary: This article explores the use of machine learning models and explainable artificial intelligence frameworks in oncology research to improve model interpretability. The frameworks provide insights into how the models make predictions and offer intuitive visualizations and interpretable sets of rules. Use cases include prognostication, diagnosis, radiomics, pathology, treatment selection, radiation treatment workflows, and epidemiology.

TRANSLATIONAL CANCER RESEARCH (2022)

Review Biology

Leveraging deep learning algorithms for synthetic data generation to design and analyze biological networks

Srisairam Achuthan et al.

Summary: The use of synthetic data and deep learning methods are increasingly important in healthcare and biomedical research, particularly in generating synthetic data from unstructured formats. Specific case studies show the effectiveness of these methods.

JOURNAL OF BIOSCIENCES (2022)

Article Oncology

Clinical Inflection Point Detection on the Basis of EHR Data to Identify Clinical Trial-Ready Patients With Cancer

Kenneth L. Kehl et al.

Summary: A deep neural network natural language processing (NLP) model was trained to dynamically predict cancer patients' prognoses and propensity to start new palliative-intent systemic therapy within 30 days. The model demonstrated good performance in identifying patients who could benefit from real-time screening for clinical trials.

JCO CLINICAL CANCER INFORMATICS (2021)

Review Oncology

Deep learning in cancer pathology: a new generation of clinical biomarkers

Amelie Echle et al.

Summary: Clinical workflows in oncology rely on molecular biomarkers for prediction and prognosis. Deep learning technology can extract biomarkers directly from routine histology images, potentially enhancing clinical decision-making, but require rigorous external validation in clinical settings.

BRITISH JOURNAL OF CANCER (2021)

Article Oncology

Predicting Survival Duration With MRI Radiomics of Brain Metastases From Non-small Cell Lung Cancer

Bihong T. Chen et al.

Summary: The study used radiomic analysis of brain metastases from NSCLC and found that radiomic scores can serve as non-invasive biomarkers for predicting survival duration. By utilizing radiomic features of EGFR, ALK, and KRAS mutations, each mutation-positive group could be divided into two subgroups with significantly different survival durations.

FRONTIERS IN ONCOLOGY (2021)

Article Oncology

Artificial intelligence for clinical oncology

Benjamin H. Kann et al.

Summary: This article discusses the challenges faced in clinical oncology, proposes a pathway for narrow-task AI applications in clinical cancer care, and emphasizes the importance of clinical validity, utility, and usability.

CANCER CELL (2021)

Article Critical Care Medicine

Usefulness of Circulating Tumor DNA in Identifying Somatic Mutations and Tracking Tumor Evolution in Patients With Non-small Cell Lung Cancer

Moom R. Roosan et al.

Summary: The study found that ctDNA analysis exhibited similar usefulness to tissue biopsy analysis in patients with NSCLC, but more mutations in targetable genes were detected in ctDNA samples compared to tissue biopsy samples. Additionally, there was a high level of gene-level concordance between ctDNA and tissue samples.

CHEST (2021)

Article Oncology

First-line immune-based combination therapies for advanced non-small cell lung cancer: A Bayesian network meta-analysis

Ziyang Mao et al.

Summary: The study conducted a Bayesian network meta-analysis of first-line immune-based combination therapies for advanced NSCLC, showing that IO + IO + Chemo may be the best mode in PD-L1 expression non-selective patients, while IO + Anti-angio + Chemo seemed more effective in the PD-L1-high cohort.

CANCER MEDICINE (2021)

Review Oncology

Artificial intelligence in oncology: Path to implementation

Isaac S. Chua et al.

Summary: The field of artificial intelligence in oncology has seen significant growth in recent years, with AI solutions being developed to address various cancer-related challenges. However, barriers to widespread adoption of AI tools in oncology exist, including biased data, lack of standardized research reporting, and outdated legal frameworks. Overcoming these obstacles will require efforts such as training oncology professionals in AI, standardizing data and model validation methods, and increasing funding for future research.

CANCER MEDICINE (2021)

Article Oncology

Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery

Joe Y. Chang et al.

Summary: Long-term results from the revised STARS trial showed that survival after SABR is non-inferior to VATS L-MLND for operable stage IA NSCLC. SABR remains promising for such cases, with multidisciplinary management strongly recommended.

LANCET ONCOLOGY (2021)

Article Oncology

Effect of Postoperative Radiotherapy for Patients With pIIIA-N2 Non-Small Cell Lung Cancer After Complete Resection and Adjuvant Chemotherapy The Phase 3 PORT-C Randomized Clinical Trial

Zhouguang Hui et al.

Summary: The study evaluated the impact of postoperative radiotherapy (PORT) on survival and safety in patients with pIIIA-N2 non-small cell lung cancer. The results showed that PORT did not improve disease-free survival but helped reduce local recurrence.

JAMA ONCOLOGY (2021)

Article Oncology

Evaluation of Somatic Mutations in Solid Metastatic Pan-Cancer Patients

Moom R. Roosan et al.

Summary: Cancer metastasis is a leading cause of cancer-related deaths. The study evaluated the mutational landscape of seven solid metastatic tumors and found that somatic mutations in certain gene pairs had opposite effects on overall survival. Targeted therapy usage was associated with longer progression-free survival in advanced cancer cases.

CANCERS (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

CT Radiomics Signature of Tumor and Peritumoral Lung Parenchyma to Predict Nonsmall Cell Lung Cancer Postsurgical Recurrence Risk

Tugba Akinci D'Antonoli et al.

ACADEMIC RADIOLOGY (2020)

Article Biochemistry & Molecular Biology

Identifying circulating miRNA biomarkers for early diagnosis and monitoring of lung cancer

Yu-Hang Zhang et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2020)

Article Respiratory System

Understanding barriers to lung cancer screening in primary care

Julia M. Coughlin et al.

JOURNAL OF THORACIC DISEASE (2020)

Review Medicine, Research & Experimental

The emerging roles of artificial intelligence in cancer drug development and precision therapy

Guosheng Liang et al.

BIOMEDICINE & PHARMACOTHERAPY (2020)

Article Radiology, Nuclear Medicine & Medical Imaging

Radiomic prediction of mutation status based on MR imaging of lung cancer brain metastases

Bihong T. Chen et al.

MAGNETIC RESONANCE IMAGING (2020)

Article Oncology

Causal Bayesian gene networks associated with bone, brain and lung metastasis of breast cancer

Sung Bae Park et al.

CLINICAL & EXPERIMENTAL METASTASIS (2020)

Article Multidisciplinary Sciences

A novel drug repurposing approach for non-small cell lung cancer using deep learning

Bingrui Li et al.

PLOS ONE (2020)

Article Multidisciplinary Sciences

Bayesian networks established functional differences between breast cancer subtypes

Lucia Trilla-Fuertes et al.

PLOS ONE (2020)

Review Biochemistry & Molecular Biology

Artificial intelligence (AI) and big data in cancer and precision oncology

Zodwa Dlamini et al.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2020)

Article Respiratory System

Artificial intelligence outperforms pulmonologists in the interpretation of pulmonary function tests

Marko Topalovic et al.

EUROPEAN RESPIRATORY JOURNAL (2019)

Article Health Care Sciences & Services

Prediction of the 1-Year Risk of Incident Lung Cancer: Prospective Study Using Electronic Health Records from the State of Maine

Xiaofang Wang et al.

JOURNAL OF MEDICAL INTERNET RESEARCH (2019)

Article Biochemistry & Molecular Biology

End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography

Diego Ardila et al.

NATURE MEDICINE (2019)

Review Pathology

Pathology Image Analysis Using Segmentation Deep Learning Algorithms

Shidan Wang et al.

AMERICAN JOURNAL OF PATHOLOGY (2019)

Article Multidisciplinary Sciences

Machine learning algorithm validation with a limited sample size

Andrius Vabalas et al.

PLOS ONE (2019)

Review Surgery

Legal, regulatory, and ethical frameworks for development of standards in artificial intelligence (AI) and autonomous robotic surgery

Shane O'Sullivan et al.

INTERNATIONAL JOURNAL OF MEDICAL ROBOTICS AND COMPUTER ASSISTED SURGERY (2019)

Review Veterinary Sciences

How to read and interpret the results of a Bayesian network meta-analysis: a short tutorial

D. Hu et al.

ANIMAL HEALTH RESEARCH REVIEWS (2019)

Article Radiology, Nuclear Medicine & Medical Imaging

Computer-Aided Detection of Lung Nodules on CT With a Computerized Pulmonary Vessel Suppressed Function

ShihChung B. Lo et al.

AMERICAN JOURNAL OF ROENTGENOLOGY (2018)

Article Medicine, General & Internal

Recent advances in the management of lung cancer

Gavin S. Jones et al.

CLINICAL MEDICINE (2018)

Review Medicine, General & Internal

Role of artificial intelligence in the care of patients with nonsmall cell lung cancer

Mohamad Rabbani et al.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2018)

Article Oncology

A Quantitative CT Imaging Signature Predicts Survival and Complements Established Prognosticators in Stage I Non-Small Cell Lung Cancer

Juheon Lee et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)

Article Health Care Sciences & Services

Transforming clinical practice guidelines and clinical pathways into fast-and-frugal decision trees to improve clinical care strategies

Benjamin Djulbegovic et al.

JOURNAL OF EVALUATION IN CLINICAL PRACTICE (2018)

Letter Oncology

Low-dose CT for lung cancer screening

Alberto Ruano-Ravina et al.

LANCET ONCOLOGY (2018)

Meeting Abstract Oncology

Results from the Image Biomarker Standardisation Initiative

A. Zwanenburg et al.

RADIOTHERAPY AND ONCOLOGY (2018)

Article Biochemistry & Molecular Biology

Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning

Nicolas Coudray et al.

NATURE MEDICINE (2018)

Article Radiology, Nuclear Medicine & Medical Imaging

Early tumor response prediction for lung cancer patients using novel longitudinal pattern features from sequential PET/CT image scans

Giulia Buizza et al.

PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS (2018)

Review Health Care Sciences & Services

Medical Image Analysis using Convolutional Neural Networks: A Review

Syed Muhammad Anwar et al.

JOURNAL OF MEDICAL SYSTEMS (2018)

Review Radiology, Nuclear Medicine & Medical Imaging

Convolutional neural networks: an overview and application in radiology

Rikiya Yamashita et al.

INSIGHTS INTO IMAGING (2018)

Article Radiology, Nuclear Medicine & Medical Imaging

Developing Bayesian networks from a dependency-layered ontology: A proof-of-concept in radiation oncology

Alan M. Kalet et al.

MEDICAL PHYSICS (2017)

Review Oncology

Radiomics: the bridge between medical imaging and personalized medicine

Philippe Lambin et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2017)

Article Oncology

1070PADAPTATION OF THE IMMUNE RELATED RESPONSE CRITERIA: IRRECIST

O. Bohnsack et al.

ANNALS OF ONCOLOGY (2017)

Article Engineering, Biomedical

Computer-aided detection (CADe) and diagnosis (CADx) system for lung cancer with likelihood of malignancy

Macedo Firmino et al.

BIOMEDICAL ENGINEERING ONLINE (2016)

Review Radiology, Nuclear Medicine & Medical Imaging

Pulmonary imaging after stereotactic radiotherapy-does RECIST still apply?

Sarah A. Mattonen et al.

BRITISH JOURNAL OF RADIOLOGY (2016)

Article Radiology, Nuclear Medicine & Medical Imaging

Comparison of CT volumetric measurement with RECIST response in patients with lung cancer

S. A. Hayes et al.

EUROPEAN JOURNAL OF RADIOLOGY (2016)

Article Radiology, Nuclear Medicine & Medical Imaging

Radiomics: Images Are More than Pictures, They Are Data

Robert J. Gillies et al.

RADIOLOGY (2016)

Article Cell Biology

Supervised autonomous robotic soft tissue surgery

Azad Shademan et al.

SCIENCE TRANSLATIONAL MEDICINE (2016)

Article Computer Science, Information Systems

A Predictive Model for Personalized Therapeutic Interventions in Non-small Cell Lung Cancer

Nelofar Kureshi et al.

IEEE JOURNAL OF BIOMEDICAL AND HEALTH INFORMATICS (2016)

Article Critical Care Medicine

Noninvasive Computed Tomography-based Risk Stratification of Lung Adenocarcinomas in the National Lung Screening Trial

Fabien Maldonado et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)

Review Surgery

Robotic thoracic surgery: The state of the art

Arvind Kumar et al.

JOURNAL OF MINIMAL ACCESS SURGERY (2015)

Article Radiology, Nuclear Medicine & Medical Imaging

The Cancer Imaging Archive (TCIA): Maintaining and Operating a Public Information Repository

Kenneth Clark et al.

JOURNAL OF DIGITAL IMAGING (2013)

Article Biochemistry & Molecular Biology

PREDICT: a method for inferring novel drug indications with application to personalized medicine

Assaf Gottlieb et al.

MOLECULAR SYSTEMS BIOLOGY (2011)

Article Engineering, Biomedical

A methodology for automatic intensity-modulated radiation treatment planning for lung cancer

Xiaodong Zhang et al.

PHYSICS IN MEDICINE AND BIOLOGY (2011)

Article Mathematical & Computational Biology

Checking consistency in mixed treatment comparison meta-analysis

S. Dias et al.

STATISTICS IN MEDICINE (2010)

Article Oncology

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

E. A. Eisenhauer et al.

EUROPEAN JOURNAL OF CANCER (2009)

Article Computer Science, Artificial Intelligence

Prediction of postoperative morbidity after lung resection using an artificial neural network ensemble

G Santos-Garcia et al.

ARTIFICIAL INTELLIGENCE IN MEDICINE (2004)

Article Mathematical & Computational Biology

Network meta-analysis for indirect treatment comparisons

T Lumley

STATISTICS IN MEDICINE (2002)

Article Cardiac & Cardiovascular Systems

Neural networks as a prognostic tool of surgical risk in lung resections

H Esteva et al.

ANNALS OF THORACIC SURGERY (2002)